Clinical Science · 2022 · 198 citations · 269 references
MedicineNephrologyPathologyEndocytosisRenal PathologyRenal PathophysiologyChronic Kidney DiseaseDiabetic NephropathyGlomerular DiseasesGlomerular InjuryPodocyte InjuryRenal DiseaseAutophagy Dysregulation In PodocytesDiabetic GlomerulosclerosisKidney DiseasesMitochondrial Dysfunction In PodocytesOxidative Stress In PodocytesOxidative Stress InjuryPodocyte BiologyPodocyte Mitochondrial Injury
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine.
269
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +17
The Pathobiology of Diabetic Complications
Michael Brownlee · Diabetes · 2005 · 5.3K citations · Full text
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris, Rajiv Agarwal, Stefan D. Anker et al. · New England Journal of Medicine · 2020 · 2.6K citations · Full text
Noboru Mizushima, Akitsugu Yamamoto, Makoto Matsui et al. · Molecular Biology of the Cell · 2003 · 2.3K citations · Full text